| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.00B | 104.75B | 86.46B | 94.92B | 84.00B | 89.16B |
| Gross Profit | 12.92B | 14.60B | 12.73B | 14.10B | 12.72B | 12.97B |
| EBITDA | 6.20B | 7.49B | 6.06B | 7.79B | 6.96B | 7.51B |
| Net Income | 3.76B | 4.37B | 3.69B | 5.09B | 5.44B | 4.74B |
Balance Sheet | ||||||
| Total Assets | 83.00B | 122.42B | 92.41B | 91.09B | 88.58B | 81.64B |
| Cash, Cash Equivalents and Short-Term Investments | 14.01B | 19.64B | 13.22B | 18.89B | 27.32B | 16.40B |
| Total Debt | 3.31B | 21.59B | 12.70B | 4.43B | 4.43B | 6.28B |
| Total Liabilities | 34.53B | 67.66B | 42.54B | 43.70B | 45.88B | 43.28B |
| Stockholders Equity | 46.93B | 54.00B | 48.32B | 45.93B | 41.32B | 37.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -260.00M | -11.35B | -5.50B | 14.17B | 14.67B |
| Operating Cash Flow | 0.00 | 311.00M | -10.26B | -4.03B | 15.07B | 15.95B |
| Investing Cash Flow | 0.00 | -1.16B | -1.85B | -3.61B | -1.33B | -1.48B |
| Financing Cash Flow | 0.00 | 7.25B | 6.45B | -1.31B | -2.90B | -12.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥40.13B | 8.67 | ― | 3.97% | -3.24% | 60.95% | |
70 Outperform | ¥45.78B | 11.08 | ― | 3.78% | 24.67% | 72.89% | |
67 Neutral | ¥61.19B | 9.90 | ― | 2.56% | 2.50% | 21.22% | |
66 Neutral | ¥64.07B | 14.10 | ― | 3.84% | -2.49% | 23.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥54.86B | 12.88 | ― | 1.57% | 4.01% | 21.41% | |
54 Neutral | ¥41.83B | 9.80 | ― | 2.84% | 21.15% | 18.25% |